Royal Bank of Canada
CGNT

Royal Bank of Canada’s Cogentix Medical, Inc. CGNT Stock Holding History

Royal Bank of Canada’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3
Closed – – 7248
2017
Q3 		$0 Buy
+3
New +$7 ﹤0.01% 7232
2017
Q2 		– Sell
-800
Closed -$2K – 6998
2017
Q1 		$2K Sell
800
-726
-48% -$1.43K ﹤0.01% 6469
2016
Q4 		$3K Hold
1,526
– – ﹤0.01% 6441
2016
Q3 		$3K Hold
1,526
– – ﹤0.01% 6133
2016
Q2 		$1K Hold
1,526
– – ﹤0.01% 6305
2016
Q1 		$1K Hold
1,526
– – ﹤0.01% 6273
2015
Q4 		$2K Buy
1,526
+300
+24% +$410 ﹤0.01% 6411
2015
Q3 		$2K Hold
1,226
– – ﹤0.01% 6421
2015
Q2 		$2K Buy
+1,226
New +$2.01K ﹤0.01% 6396

Other funds holding CGNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's CGNT Position: Q4 2017 in Review

Royal Bank of Canada sold out of Cogentix Medical, Inc. (CGNT) in Q4 2017, closing a stake of 3 shares.

Royal Bank of Canada first reported a position in CGNT in Q2 2015 and held it in 9 quarters. The position peaked at $3K in Q4 2016. 44 funds tracked by Wall St. Rank hold CGNT as of Q4 2017.

  • Royal Bank of Canada reported no remaining Cogentix Medical, Inc. position as of Q4 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 3 Cogentix Medical, Inc. shares in Q4 2017.
  • Royal Bank of Canada first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 9 quarters.
  • Royal Bank of Canada's Cogentix Medical, Inc. position peaked at $3K in Q4 2016.
  • 44 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q4 2017.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.